Document is current
Any future updates will be listed below
-
Authors
Wang, Jiayu
Zhang, Qingyuan https://orcid.org/0000-0001-8116-5293
Li, Huiping
Tong, Zhongsheng
Ouyang, Quchang
Li, Huihui
Teng, Yuee
Wang, Biyun
Sun, Tao
Wang, Jingfen
Li, Wei
Niu, Zhaofeng
Li, Hongsheng
Gong, Chang
Wang, Shu https://orcid.org/0000-0002-8651-4795
Wang, Xinshuai
Wu, Xinhong
Liu, Ning
Yu, Guohua
Liu, Fei
Duan, Xianghui
Wang, Shuya
Meng, Yaping
Wang, Li
Xu, Binghe https://orcid.org/0000-0003-4195-337X
-
Funding
Funding for this research was provided by:
CAMS Innovation Fund for Medical Sciences
National Major Scientific and Technological Special Project for "Significant New Drugs Development"
- License Information
-
More Information
Article History
Received: 11 October 2024
Accepted: 31 March 2025
First Online: 9 April 2025
Competing interests
: F.L., X.H.D., S.Y.W., Y.P.M., and L.W. are employees of Xuanzhu Biopharmaceutical Co., Ltd. B.H.X. reported receiving consulting fees and payment for lectures from AstraZeneca and Novartis outside the submitted work. The remaining authors declare no competing interests.
